发明授权
US08530482B2 Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates
有权
卤化吡唑并[1,5-A]嘧啶,方法,用途,组合物和中间体
- 专利标题: Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates
- 专利标题(中): 卤化吡唑并[1,5-A]嘧啶,方法,用途,组合物和中间体
-
申请号: US11922602申请日: 2006-06-15
-
公开(公告)号: US08530482B2公开(公告)日: 2013-09-10
- 发明人: Luis Anglada , Albert Palomer , Antonio Guglietta
- 申请人: Luis Anglada , Albert Palomer , Antonio Guglietta
- 申请人地址: ES Barcelona
- 专利权人: Ferrer Internacional, S.A.
- 当前专利权人: Ferrer Internacional, S.A.
- 当前专利权人地址: ES Barcelona
- 代理机构: Birch, Stewart, Kolasch & Birch, LLP
- 优先权: EP05105478 20050621
- 国际申请: PCT/EP2006/063243 WO 20060615
- 国际公布: WO2006/136530 WO 20061228
- 主分类号: A01N43/90
- IPC分类号: A01N43/90 ; A61K31/519 ; C07D487/00
摘要:
The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R1, X and Y have different meanings, and pharmaceutically acceptable salts thereof. Compounds of formula (I) are useful for treating or preventing anxiety, epilepsy and sleep disorders including insomnia, and for inducing sedation-hypnosis, anesthesia, sleep and muscle relaxation. The invention also provides synthetic procedures for preparing said compounds and certain intermediates, as well as intermediates themselves.
公开/授权文献
信息查询
IPC分类: